Results 221 to 230 of about 249,987 (395)
Diversification with the Option-to-Abandon: An Integrated Valuation Model [PDF]
Carlos Alberto de Souza
openalex +1 more source
Deconstructing the Construction of Value in Anorexia Nervosa. [PDF]
Lloyd EC, Steinglass JE, Foerde KE.
europepmc +1 more source
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source
Valuation for an American Continuous-Installment Put Option on Bond under Vasicek Interest Rate Model [PDF]
Guoan Huang, Guohe Deng, Lihong Huang
openalex +1 more source
Building momentum: A computational account of persistence toward long-term goals. [PDF]
Aenugu S, O'Doherty JP.
europepmc +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias+12 more
wiley +1 more source
Parametric Properties of Semi-Nonparametric Distributions, with Applications to Option Valuation [PDF]
Ángel León+2 more
openalex +1 more source
A Novel approach to ship valuation prediction: An application to the supramax and ultramax secondhand markets. [PDF]
Bal ET, Akan E, Gencer H.
europepmc +1 more source
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul+11 more
wiley +1 more source
Framework to identify innovative sources of value creation from platform technologies. [PDF]
Jones CH+7 more
europepmc +1 more source